<DOC>
	<DOCNO>NCT01470092</DOCNO>
	<brief_summary>Longitudinal epidemiological study show many woman experience significant physical psychological change approach menopause long time follow . Vasomotor symptom ( hot flush , night sweat ) , sleep disturbance change libido common , impact significantly quality life , social personal well-being . However , major reason many woman seek help menopause clinic doctor , depression anxiety symptom . As , treatment commonly draw traditional approach management major depression include use antidepressant selective serotonin reuptake inhibitor ( SSRIs ) Selective Norepinephrine Reuptake Inhibitors ( SNRIs ) first line response . However , standard treatment menopausal depression use antidepressant show small improvement best worst , associate severe side effect . Some SSRIs show less effective postmenopausal woman compare child bearing age woman . Newer therapy directly target disrupt hormonal system ( particular estrogen ) administration compound tibolone , show significant potential treat depression add benefit few adverse side effect . With grow evidence support use tibolone viable improve treatment menopausal depression , investigator propose investigate potential tibolone , selective Hormone Replacement Therapy ( HRT ) , ameliorate de-novo first onset depression occur menopausal period .</brief_summary>
	<brief_title>Tibolone Placebo Adjunct Antidepressant Medication Women With Menopausal Depression</brief_title>
	<detailed_description>All woman experience menopause significant number suffer ongoing , severe depression begin major hormone fluctuation middle stage life . Longitudinal epidemiological study show many woman experience significant physical psychological change approach menopause long time follow . Vasomotor symptom ( hot flush , night sweat ) , sleep disturbance change libido common , impact significantly quality life , social personal well-being . However , major reason many woman seek help menopause clinic doctor depression anxiety symptom . Indeed , many menopausal woman past psychiatric history experience severe mood symptom menopause first time life , serious debilitate long term consequence . Treatment depression commonly draw traditional approach management major depression include use antidepressant selective serotonin reuptake inhibitor ( SSRIs ) selective norepinephrine reuptake inhibitor ( SNRIs ) first line response . However , standard treatment menopausal depression use antidepressant show small improvement best worst , associate severe side effect . Some SSRIs show less effective postmenopausal woman compare woman child bear age . Newer therapy directly target fluctuation reproductive hormonal hormone system ( particular estrogen , progesterone testosterone ) administration compound tibolone , show significant potential treat depression add benefit few adverse side effect . With grow evidence support use tibolone viable improve treatment menopausal depression , investigator propose investigate potential tibolone , selective Hormone Replacement Therapy ( HRT ) , ameliorate de-novo relapse depression occur menopausal period . Women menopausal depression either currently use use SSRI SNRI medication involve 12 week randomize control trial may randomise one two group : ) Tibolone ( 2.5mg oral/day ) ii ) placebo . It hypothesize woman receive Tibolone adjunct standard antidepressant medication , significantly great improvement depressive symptom compare woman receive placebo adjunct standard antidepressant medication woman use psychotropic/hormone treatment .</detailed_description>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Tibolone</mesh_term>
	<mesh_term>Antidepressive Agents</mesh_term>
	<criteria>Females currently physically well 45 65 year age Current DSMIV diagnosis depression disorder Able give inform consent Menopausal determine standardized classification guideline female reproductive age propose Stages Reproductive ( STRAW ) Aging Workshop symptom profile STRAW Firstonset relapse depression menopause Currently take either SSRI SNRI , psychotropic medication Evidence normal mammogram precede 12 month . Patients known abnormality hypothalamicpituitary gonadal axis , thyroid dysfunction , central nervous system tumour , active past history venous thromboembolic event , breast pathology , undiagnosed vaginal bleeding abnormal Pap smear result previous 2 year . Patients significant unstable medical illness epilepsy diabetes know active cardiac , renal liver disease ; presence illness cause immobilisation . Patients experience severe melancholia , neurovegetative symptom current suicidality necessitate acute hospitalisation intensive psychiatric treatment . Patients psychotic symptom past history severe mental illness include schizophrenia . Use form estrogen , progestin androgen hormonal therapy , antiandrogen include Tibolone use phytoestrogen supplement powder tablet Pregnancy / Lactation Smoking cigarettes nicotine product Illicit drug use More 3 standard drink per day</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Depression</keyword>
</DOC>